Sunrise Announces Landmark Results from the SUNSAS Trial, the Largest Randomized Controlled Study of an At-Home Sleep Apnea Diagnostic Pathway Compared with PSG

AI Briefing

• – Sunrise Group announces results from the SUNSAS trial, the largest randomized controlled study of an at-home sleep apnea diagnostic pathway, comparing it to PSG with a promising outcome.
• – The trial, supported by the French Ministry of Health, evaluates the effectiveness of the at-home diagnostic pathway for obstructive sleep apnea.
• – The study's findings were published in The Lancet Regional Health – Europe, a leading international medical journal.